Gene expression profiles in microdissected neurons from human hippocampal subregions

Department of Pathology, University of Miami School of Medicine (R-5), 1550 NW, Tenth Avenue, Miami, FL 33136, USA.
Molecular Brain Research (Impact Factor: 2). 09/2004; 127(1-2):105-14. DOI: 10.1016/j.molbrainres.2004.05.017
Source: PubMed

ABSTRACT Pyramidal neurons in hippocampal subregions are selectively vulnerable in certain disease states. To investigate, we tested the hypothesis that selective vulnerability in human hippocampus is related to regional differences in neuronal cell death and cell receptor gene expression in CA1 vs. CA3 subregions. We used laser capture microdissection to remove approximately 600 CA1 and 600 CA3 pyramidal neurons each from five fresh-frozen normal post-mortem brains, extracted total RNA and double-amplified mRNA. This was reverse transcribed and labeled for hybridization onto human cDNA array chips containing probes to 10,174 genes and unknown ESTs. RNA from additional microdissections was pooled for replicate hybridizations and quantitative RT-PCR validation. Gene expression differences were few (< 1%). We found 43 enriched genes in CA1 neuronal samples that included peripheral benzodiazipine receptor-associated protein, nicotinic cholinergic receptor, two chemokine receptors (CCR1 and CCR5) and several transcriptional factors. We found 17 enriched genes in the CA3 neuronal samples that included fibroblast growth factor receptor and prostaglandin-endoperoxide synthase 1. We found no differential gene expression for 23 calcium channel proteins; nine transporter proteins; 55 cell death and apoptotic regulator proteins; and an additional 497 cell receptors, including 24 glutamate receptors. Quantitative RT-PCR of four differentially expressed genes confirmed the microarray data. The results confirm the ability to examine gene expression profiles in microdissected neurons from human autopsy brain. They show only minor gene expression differences between two distinct neuronal populations in the hippocampus and suggest that selective hippocampal vulnerability is due to factors other than intrinsic differential expression in glutamate receptors and cell death genes.

Download full-text


Available from: Jorge E Torres-Muñoz, Aug 25, 2015
  • Source
    • "The Ccr5 mRNA probe did not yield any signal in CCR5-deficient mouse brain sections (Figure 3C). In agreement with previous reports (Rottman et al., 1997; Westmoreland et al., 2002; Torres-Munoz et al., 2004), we observed that Ccr5 was present in neurons, astrocytes and microglia (Figure 3D–F). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The chemokine receptor CCR5 is well known for its function in immune cells; however, it is also expressed in the brain, where its specific role remains to be elucidated. Because genetic factors may influence the risk of developing cerebral ischaemia or affect its clinical outcome, we have analysed the role of CCR5 in experimental stroke. Permanent cerebral ischaemia was performed by occlusion of the middle cerebral artery in wild-type and CCR5-deficient mice. Locomotor behaviour, infarct size and histochemical alterations were analysed at different time points after occlusion. The cerebral vasculature was comparable in wild-type and CCR5-deficient mice. However, the size of the infarct and the motor deficits after occlusion were markedly increased in CCR5-deficient mice as compared with wild type. No differences between wild-type and CCR5-deficient mice were elicited by occlusion with respect to the morphology and abundance of astrocytes and microglia. Seven days after occlusion the majority of CCR5-deficient mice displayed neutrophil invasion in the infarct region, which was not observed in wild type. As compared with wild type, the infarct regions of CCR5-deficient mice were characterized by increased neuronal death. Lack of CCR5 increased the severity of brain injury following occlusion of the middle cerebral artery. This is of particular interest with respect to the relatively frequent occurrence of CCR5 deficiency in the human population (1-2% of the Caucasian population) and the advent of CCR5 inhibitors as novel drugs.
    British Journal of Pharmacology 05/2010; 160(2):311-21. DOI:10.1111/j.1476-5381.2010.00697.x · 4.99 Impact Factor
  • Source
    • "Hence, the differences in gene expression between brain regions susceptible and resistant to ischemia are not big enough to explain the presented phenomenon. Consequently, the unique susceptibility to ischemia of particular brain neurons should not be connected exclusively with the differences in expression of the genes involved in cell death processes, apoptosis regulation, cell growth or glutamate receptor expression (Torres-Munoz et al. 2004). The neurons considered more resistant to ischemia may be characterized by increased metabolism and greater energetic reserve, resulting in, among other things, a higher expression of the genes related to glycolysis (Datson et al. 2004; Newrzella et al. 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is large body of evidence suggesting distinct susceptibility to ischemia in various brain regions. However, the reason for this remains unexplained. Comparative studies of programmed cell death (PCD) pathways indicate their differentiated evolutional origin. The caspase-independent pathway is regarded as an older, whereas the caspase-dependent--as more advanced. In our study we address the question of whether there are any characteristic differences in the activation and course of PCD in phylogenetically and morphologically distinguished brain structures after transient focal ischemia. Using Western blot, we studied changes in expression of caspases: 3, 8, 9, and AIF in the frontoparietal neocortex, archicortex (CA1 and CA2 sectors of the hippocampus) and striatum, during reperfusion after 1 h occlusion of the middle cerebral artery. The caspase and AIF expression were differentiated between the studied structures. The activation of only the caspase-dependent pathway was observed in the neocortex. In the archicortex and striatum both caspase-dependent and caspase-independent pathways were activated, although in the latter the extrinsic apoptotic pathway was not activated. In summary, it is conceivable that structures of different evolutionary origin undergo cell-death processes with the participation of phylogenetically distinguished mechanisms. The previously reported unequal susceptibility to ischemia may co-exist with activation of different cell death pathways.
    Metabolic Brain Disease 09/2009; 24(3):507-23. DOI:10.1007/s11011-009-9149-2 · 2.40 Impact Factor
  • Source
    • "No regional differences in expression have been found for the other MBD proteins, with the exception of MBD3, which shows higher levels of expression in the CA1–4 as compared to the dentate gyrus during embryonic development, but these differences are lost in adulthood [16]. A number of studies have examined differential mRNA expression between the CA1 and CA3 regions of the hippocampus [13] [32]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent observations suggest that DNA methylation plays an important role in memory and long-term potentiation (LTP) in the hippocampus and is involved in programming the offspring epigenome in response to maternal care. Global DNA methylation is believed to be stable postnatally and to be similar across tissues in the adult mammal. It has also been a long held belief that DNA methyltransferases (DNMTs) play a very limited role in postmitotic tissues. Recent data suggests a more dynamic role for DNA methylation in the brain postnatally, therefore we examined the global state of methylation and the expression of the known DNMTs in the different regions of the hippocampus. We observed strikingly different levels of global methylation in the adult rat dentate gyrus (DG) and CA1 region in comparison with the CA2 and CA3 regions. mRNA levels of DNA methyltransferases exhibited similar regional specificity and were correlated with global DNA methylation levels. These regional differences in global methylation and expression of the DNA methylation machinery in the adult brain are consistent with the emerging hypothesis that DNA methylation may play a dynamic physiological role in the adult brain.
    Neuroscience Letters 08/2008; 440(1):49-53. DOI:10.1016/j.neulet.2008.05.028 · 2.06 Impact Factor
Show more